Cara Therapeutics Inc. | Mutual Funds
Mutual Funds that own Cara Therapeutics Inc.
SPDR S&P Biotech ETF
1,326,408
3.38%
3,411
0.46%
09/06/2018
Vanguard Total Stock Market Index Fund
816,863
2.08%
174,900
0%
07/31/2018
iShares Russell 2000 ETF
574,019
1.46%
-306
0.02%
09/06/2018
Fidelity Select Biotechnology Portfolio
534,675
1.36%
0
0.12%
07/31/2018
iShares Nasdaq Biotechnology ETF
437,825
1.11%
-5,733
0.09%
09/06/2018
Vanguard Extended Market Index Fund
429,946
1.09%
66,654
0.01%
07/31/2018
362,698
0.92%
0
1.6%
09/06/2018
T Rowe Price Health Sciences Fund
351,232
0.89%
-7,168
0.06%
06/30/2018
Carmignac Portfolio - Euro Patrimoine
321,947
0.82%
321,947
1.43%
06/29/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
290,900
0.74%
0
0.25%
06/30/2018
| Address |
4 Stamford Plaza
Stamford Connecticut 06902
United States
|
|
Employees
|
- |
| Website |
http://www.caratherapeutics.com |
| Updated |
07/08/2019 |
| CARA Therapeutics, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. |
